These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 9078990)
21. Management of panic disorder. Lader M Expert Rev Neurother; 2005 Mar; 5(2):259-66. PubMed ID: 15853495 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological treatment of major depressive disorder in adolescents. Farley RL ScientificWorldJournal; 2005 May; 5():420-6. PubMed ID: 15915296 [TBL] [Abstract][Full Text] [Related]
23. Panic disorder: A review of treatment options. Ziffra M Ann Clin Psychiatry; 2021 May; 33(2):124-133. PubMed ID: 33529291 [TBL] [Abstract][Full Text] [Related]
24. Panic disorder: long-term pharmacotherapy and discontinuation. Rickels K; Schweizer E J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological treatment of panic disorder. Bandelow B; Baldwin DS; Zwanzger P Mod Trends Pharmacopsychiatry; 2013; 29():128-43. PubMed ID: 25225023 [TBL] [Abstract][Full Text] [Related]
26. Overview of antidepressants currently used to treat anxiety disorders. Feighner JP J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351 [TBL] [Abstract][Full Text] [Related]
27. A risk-benefit assessment of pharmacological treatments for panic disorder. Bennett JA; Moioffer M; Stanton SP; Dwight M; Keck PE Drug Saf; 1998 Jun; 18(6):419-30. PubMed ID: 9638387 [TBL] [Abstract][Full Text] [Related]
29. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder. Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622 [TBL] [Abstract][Full Text] [Related]
30. Translating the evidence on atypical depression into clinical practice. Rapaport MH; Thase ME J Clin Psychiatry; 2007 Apr; 68(4):e11. PubMed ID: 17474801 [TBL] [Abstract][Full Text] [Related]
31. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Otto MW; Tuby KS; Gould RA; McLean RY; Pollack MH Am J Psychiatry; 2001 Dec; 158(12):1989-92. PubMed ID: 11729014 [TBL] [Abstract][Full Text] [Related]
32. The symptoms, neurobiology, and current pharmacological treatment of depression. To SE; Zepf RA; Woods AG J Neurosci Nurs; 2005 Apr; 37(2):102-7. PubMed ID: 15902953 [TBL] [Abstract][Full Text] [Related]
33. Antidepressants in panic disorder: clinical and preclinical mechanisms. Nutt DJ J Clin Psychiatry; 1998; 59 Suppl 8():24-8; discussion 29. PubMed ID: 9707159 [TBL] [Abstract][Full Text] [Related]
34. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia. Pohl R; Berchou R; Rainey JM J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863 [TBL] [Abstract][Full Text] [Related]
36. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings. Gómez Gómez JM; Teixidó Perramón C J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150 [TBL] [Abstract][Full Text] [Related]
37. Rational drug use in the treatment of depression. Cohen LJ Pharmacotherapy; 1997; 17(1):45-61. PubMed ID: 9017765 [TBL] [Abstract][Full Text] [Related]
38. Maintenance treatment with antidepressants in panic disorder. Noyes R; Perry P J Clin Psychiatry; 1990 Dec; 51 Suppl A():24-30. PubMed ID: 2258373 [TBL] [Abstract][Full Text] [Related]
39. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports. Madhusoodanan S; Alexeenko L; Sanders R; Brenner R Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187 [TBL] [Abstract][Full Text] [Related]